LadRx Corporation Quality Score
LADX
Valuation is the primary weakness (avg 0/100). Business quality is the relative bright spot.
Broad-market heuristics · Not a buy/sell signal
Valuation and growth
Valuation
Growth
Negative earnings, no valuation support
Not enough quarterly data
for a 1-year trend
Negative FCF, no valuation support
Not enough quarterly data
for a 1-year trend
Above 10% CAGR, strong compounder
FCF negative, burning cash after capex
Business Quality & Capital Allocation
Shrinking >2%, active buybacks
Expanded 3+pp, strong improvement
Net cash position, no leverage concern
Below 8%, may not cover cost of capital
LadRx (LADX) quality: score, margins and returns
LadRx (LADX) scores 50/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 6 metrics each scored 0 to 100 and -4,061.1% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.
Frequently asked
Is LadRx (LADX) a high-quality business?+
LadRx scores 50 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a -4,061.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.
What does LadRx's quality score measure?+
Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from LADX's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where LadRx scores well and where it falls behind.
What is LadRx's return on invested capital (ROIC)?+
LadRx earns about -4,061.1% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to LADX's margins and growth on this scorecard to judge durability.
SourceQuality score computed from the 10-Q filed 14 May 2025, covering the period ending 31 Mar 2025, as reported to the SEC. Data last refreshed 21 Aug 2026. How this is calculated.
Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LADX
Spot a number that looks wrong? Check it in LADX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LADX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.